Racecadotril Film-Coated Tablet (FCT) + Racecadotril Capsule

Phase 1Completed

1 views this week 0 watching💤 Quiet

Interest: 29/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Antidiarrheals

Conditions

Antidiarrheals

Trial Timeline

Jan 1, 2011 → Jan 1, 2011

NCT ID

NCT01302093

About Racecadotril Film-Coated Tablet (FCT) + Racecadotril Capsule

Racecadotril Film-Coated Tablet (FCT) + Racecadotril Capsule is a phase 1 stage product being developed by Johnson & Johnson for Antidiarrheals. The current trial status is completed. This product is registered under clinical trial identifier NCT01302093. Target conditions include Antidiarrheals.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01302093	Phase 1	Completed	Jan 1, 2011	Jan 1, 2011	Antidiarrheals